Clinical Trial Update: OMERACT SLE Delphi

View source ↗

Summary

An update on the OMERACT SLE Delphi study to reach consensus on outcome measures for systemic lupus erythematosus; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Snippet

Sponsor: University Health Network, Toronto | Conditions: SLE - Systemic Lupus Erythematosus | Status: NOT_YET_RECRUITING